Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fase III Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

NCT02532660 is registered in ClinicalTrials.gov with Laboratório Catarinense SA as lead sponsor.

NCT NCT02532660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02532660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fase III Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode
Lead sponsor
Laboratório Catarinense SA
Phase
Phase 3
Overall status
Terminated
Start date
July 2, 2018
Completion date
June 1, 2022
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression